TrialBlood cancer journal2020

Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients.

Jordan E Krull et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.